Combination treatment of CC531-lac-Z rat liver metastases by chemoembolization with pemetrexed disodium and gemcitabine

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 5, 2005, Pages 289-299

  Rodenbach, Michael ^a   Eyol, Ergül ^a   Seelig, Matthias H ^b   Berger, Martin R ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

CC531 lac Z; Chemoembolization; Chemoluminescence; Gemcitabine; Pemetrexed disodium

Indexed keywords

ANTINEOPLASTIC AGENT; BETA GALACTOSIDASE; BROMINE DERIVATIVE; GEMCITABINE; PEMETREXED;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TRANSPLANTATION; CHEMOEMBOLIZATION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG MEGADOSE; ENZYME ACTIVITY; EVALUATION; HEPATIC ARTERY LIGATION; IN VITRO STUDY; LIVER METASTASIS; MALE; MEASUREMENT; NONHUMAN; PATIENT; PORTAL VEIN; PRIORITY JOURNAL; RAT; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CHEMOEMBOLIZATION, THERAPEUTIC; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DEATH; DEOXYCYTIDINE; DISEASE MODELS, ANIMAL; GLUTAMATES; GUANINE; LIVER NEOPLASMS; MALE; NEOPLASM METASTASIS; RATS; RATS, INBRED STRAINS;

EID: 17644361933     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0643-y     Document Type: Article

References (43)

1. Ackerman NB (1974) The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery. 75:589-596
2. Adam R (2003) Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 14(suppl 2):II13-II16
3. Adjei AA (2001) Gemcitabine and pemetrexed disodium combinations in vitro and in vivo. Lung Cancer 34(suppl 4):S103-S105
4. Adjei AA (2002) Pemetrexed in the treatment of selected solid tumors. Semin Oncol 29:50-53
5. Adjei AA (2004) Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent. Clin Cancer Res 10:4276s-4280s
6. Adjei AA, Erlichman C, Sloan JA, et al. (2000) Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors. J Clin Oncol 18:1748-1757
7. Archer SG, Gray BN (1989) Vascularization of small liver metastases. Br J Surg 76:545-548
8. Archer SG, Gray BN (1990) Comparison of portal vein chemotherapy with hepatic artery chemotherapy in the treatment of liver micrometastases. Am J Surg 159:325-329
9. Ball AB (1991) Regional chemotherapy for colorectal hepatic metastases using degradable starch microspheres. A review. Acta Oncol 30:309-313
10. Bartkowski R, Berger MR, Aguiar JL, et al. (1986) Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model. J Cancer Res Clin Oncol 111:42-46
11. Blanchard RJ, Grotenhuis I, Lafave JW, Perry JF, Jr. (1965) Blood supply to hepatic V2 carcinoma implants as measured by radioactive microspheres. Proc Soc Exp Biol Med 118:465-468
12. Bodeker H, Kamphorst EJ, Wunsch PH, et al. (2003) Superiority of combined chemoembolization and portal infusion with 5-fluorouracil over locoregional infusion concepts in Novikoff hepatoma-bearing rats. J Cancer Res Clin Oncol 129:655-661
13. Breedis C, Young G (1954) The blood supply of neoplasms in the liver. Am J Pathol 30:969-977
14. Civalleri D, Esposito M, Fulco RA, et al. (1991) Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases. Cancer 68:988-994
15. Fiorentini G, Poddie DB, Cantore M, et al. (2001) Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities. Hepatogastroenterology 48:305-312
16. Fiorentini G, Poddie DB, De Giorg Ui, et al. (2000) Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments. Med Oncol 17:163-173
17. Fossella FV (2004) Pemetrexed for treatment of advanced non-small cell lung cancer. Semin Oncol 31:100-105
18. Geoghegan JG, Scheele J (1999) Treatment of colorectal liver metastases. Br J Surg 86:158-169
19. Guimbaud R (2004) Colorectal cancers: management of metastatic cancers. Rev Prat 54:167-176
20. Gutt CN, Kim ZG, Gessmann T, et al. (2000) Hepatic tumor spread of colorectal cancer in a laparoscopic animal model. Surg Endosc 14:448-451
21. Hagenaars M, Ensink NG, Basse PH, et al. (2000a) The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy? Clin Exp Metastasis 18:189-196
22. Hagenaars M, Koelemij R, Ensink NG, et al. (2000b) The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma. Clin Exp Metastasis 18:281-289
23. Kamphorst EJ, Bodeker H, Koroma S, et al. (1999) New technique for superselective arterial (chemo-) embolization of the rat liver. Lab Anim Sci 49:216-219
24. Lang EK, Brown, CL, Jr. (1993) Colorectal metastases to the liver: selective chemoembolization. Radiology 189:417-422
25. Liu LX, Zhang WH, Jiang HC (2003) Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 9:193-200
26. Llovet JM, Real MI, Montana X, et al. (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734-1739
27. Monnerat C, Le Chevalier T, Kelly K, et al. (2004) Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer. Clin Cancer Res 10:5439-5446
28. Mook OR, Van Marle J, Vreeling-Sindelarova H, et al. (2003) Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology 38:295-304
29. Ragnhammar P, Hafstrom L, Nygren P, Glimelius B (2001) A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 40:282-308
30. Richards DA, Kindler HL, Oettle H, et al. (2004) A randomized phase III study comparing gemcitabine + pemetrexed versus gemcitabine in patients with locally advanced and metastatic pancreas cancer. J Clin Oncol 22:4007
31. Rougier P, Mitry E (2003) Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol 14(suppl 2):II3-II5
32. Rudroff C, Altendorf-Hoffmann A, Stangl R, Scheele J (1999) Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbecks Arch Surg 384:243-249
33. Ruers T, Bleichrodt RP (2002) Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 38:1023-1033
34. Saenger J, Leible M, Seelig MH, Berger MR (2004) Chemoembolization of rat liver metastasis with irinotecan and quan-tification of tumor cell reduction. J Cancer Res Clin Oncol 130:203-210
35. Sanz-Altamira PM, Spence LD, Huberman MS, et al. (1997) Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Dis Colon Rectum 40:770-775
36. Seelig MH, Leible M, Sanger J, Berger MR (2004) Chemoembolization of rat liver metastasis with microspheres and gemcitabine followed by evaluation of tumor cell load by chemiluminescence. Oncol Rep 11:1107-1113
37. Starkhammar H, Hakansson L (1987) Effect of starch microspheres on the passage of labelled erythrocytes and a low molecular weight marker through the liver. Acta Oncol 26:361-365
38. Teicher BA, Chen V, Shih C, et al. (2000) Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts. Clin Cancer Res 6:1016-1023
39. Tellez C, Benson AB III, Lyster MT, et al. (1998) Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82:1250-1259
40. Tesei A, Ricotti L, De Paola F, et al. (2002) In vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell lines. Clin Cancer Res 8:233-239
41. Thomas C, Nijenhuis AM, Timens W, et al. (1993) Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. Invasion Metastasis 13:102-112
42. Tonkinson JL, Worzalla JF, Teng CH, Mendelsohn LG (1999) Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma. Cancer Res 59:3671-3676
43. Wittmer A, Khazaie K, Berger MR (1999) Quantitative detection of lac-Z-transfected CC531 colon carcinoma cells in an orthotopic rat liver metastasis model. Clin Exp Metastasis 17:369-376